The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 07, 2017
Filed:
Aug. 29, 2013
Applicants:
Alectos Therapeutics Inc., Burnaby, CA;
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Ernest J. McEachern, Vancouver, CA;
Jianyu Sun, Burnaby, CA;
David J. Vocadlo, Burnaby, CA;
Yuanxi Zhou, Burnaby, CA;
Yongbao Zhu, Burnaby, CA;
Harold G. Selnick, West Point, PA (US);
Assignees:
Alectos Therapeutics Inc., Burnaby, CA;
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/12 (2006.01); A61K 31/40 (2006.01); A61K 31/428 (2006.01); A61K 31/4439 (2006.01); C07D 401/06 (2006.01); C07D 417/06 (2006.01); C12N 9/99 (2006.01); C07D 207/16 (2006.01);
U.S. Cl.
CPC ...
C07D 207/12 (2013.01); A61K 31/40 (2013.01); A61K 31/428 (2013.01); A61K 31/4439 (2013.01); C07D 207/16 (2013.01); C07D 401/06 (2013.01); C07D 417/06 (2013.01); C12N 9/99 (2013.01); C12Y 302/01169 (2013.01);
Abstract
The invention provides compounds for inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.